Cephalon downgraded at BofA/MerrillCEPH downgraded to Neutral from Buy on valuation, Bank of America/Merrill Lynch said. Maintain $75 price target. 2010 and 2011 EPS estimates held at $6.52 and $6.70, respectively.
Cephalon target raised at UBSCEPH target was boosted to $80, UBS said. Company is seeing better prescription trends. Buy rating.
DuPont Fabros Technology initiated at BarclaysDFT coverage initiated with an Overweight rating and $25 price target, Barclays said. 2010 and 2011 EPS estimates set at $1.24 and $1.60, respectively.
Digital River upgraded at FBRDRIV was upgraded from Market Perform to Outperform, FBR Capital Markets said. Company is likely seeing an improved business pipeline. $36 price target.
Fresh Del Monte downgraded at SuntrustFDP was downgraded from Buy to Neutral, Suntrust Robinson Humphrey said. See few meaningful catalysts on the horizon.
Public Service Enterprise rated new Neutral at GoldmanPEG was initiated with a Neutral rating, Goldman Sachs said. $34 price target. Earnings growth in the regulated business will likely be offset by lower merchant generation results.
Psychiatric Solutions downgraded at Piper JaffrayPSYS downgraded at Piper Jaffray. Rating lowered to Underweight from Neutral. Price target raised to $30 from $24. Maintains 2010 EPS estimates of $2.30.
SAIC downgraded at WellsSAI was downgraded to Market Perform, Wells Fargo said. Company lowered guidance as it's seeing award delays.
WLP was upgraded from Market Perform to Outperform, BMO Capital Markets said. $75 price target.
AMAT estimates higher after positive analyst day, Credit Suisse said. 2010 and 2011 EPS estimates improved to $0.75 and $1.00, respectively. Maintain Neutral rating and $15.50 target.
Applied Materials numbers boosted at UBS
AMAT estimates were increased through 2011, UBS said. Company is seeing higher demand across the board. Buy rating and new $18 price target.
Applied Materials numbers boosted at UBSAMAT estimates were increased through 2011, UBS said. Company is seeing higher demand across the board. Buy rating and new $18 price target.
Cliffs Natural estimates raised at Morgan StanleyCLF estimates were increased through 2011, Morgan Stanley said. Company will benefit from higher iron ore prices. Equal-weight rating.
Freeport-McMoran estimates raised at Morgan StanleyFCX estimates were boosted through 2011, Morgan Stanley said. Company is positioned to benefit from higher copper prices. Equal-weight rating.
Garmin target, estimates boosted at BarclaysGRMN price target increased by dollar to $34 on strong PND growth, Barclays said. 2010 EPS estimate raised to $2.97, 2011 held at $2.75. Maintain Equal Weight rating.
Goldman Sachs numbers lowered at KBWShares of GS now seen reaching $195, according to Keefe, Bruyette & Woods. Estimates also reduced, as the company likely saw lower investment banking revenue this quarter.
Intercontinental Exchange numbers upped at Morgan StanleyShares of ICE now seen reaching $118, according to Morgan Stanley. Estimates also raised, as the copany should benefit from higher OTC and energy volumes. Equal-weight rating.
Linear Technology estimates upped at FBRLLTC estimates were raised through 2011, FBR Capital Markets said. Checks suggest that quarterly sales are tracking at the high end of expectations. Underperform rating and $31 price target.
McDermott International price target higher at BarclaysMDR price target jumped to $33 from $29 on improving prospects, Barclays said. 2010 and 2011 EPS estimates held at $1.85 and $2.15, respectively.
Maxim Integrated numbers raised at FBRShares of MXIM now seen reaching $23, according to FBR Capital Markets. Estimates also increased, following robust channel checks. Market Perform rating.
NYSE Euronext estimates lowered at Morgan StanleyNYX estimates were cut through 2011, Morgan Stanley said. Company likely seeing lower volumes and losing market share. Equal-weight rating and $31 price target.
Target numbers boosted at GoldmanShares of TGT now seen reaching $53, according to Goldman Sachs. Estimates also upped, given improving credit trends. Neutral rating.
